. 2018 Feb 8;93(5):607–614. doi: 10.1002/ajh.25043
© 2018 The Authors American Journal of Hematology Published by Wiley Periodicals, Inc.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Figure 2.
Overall survival. IMT, inflammatory myofibroblastic tumor